(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Unique device identifier (udi#): in the absence of a reported part number, the udi cannot be calculated.There was no reported device malfunction and the product was not returned as the scaffold remains in the anatomy.A review of the lot history record and complaint history could not be conducted because the part and lot numbers were not provided.The reported patient effects of myocardial infarction and thrombosis, as listed in the absorb gt1 instructions for use, is a known adverse event associated with the use of a coronary scaffold in native coronary arteries.Based on the case information, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.
|
It was reported that a 3.5 mm absorb gt1 scaffold was implanted on (b)(6) 2017 in the proximal left anterior descending (lad) coronary artery.On (b)(6) 2019, the patient presented at the emergency room with myocardial infarction (mi).Fluoroscopy confirmed thrombosis in the proximal lad; however, exact location of the thrombosis is unknown.Patient had a 3.5x15 mm xience sierra implanted as treatment and is stable and recovering.No additional information was provided.
|